RichardScottHamiltonMD

Ophthalmology • Lakeland, FL

Retinal Disease

Community based retina specialist at Retina Partners of Florida

Join to view full profile

Dr. Hamilton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hamilton's full profile

Already have an account?

Office
1910 Lakeland Hills Blvd.
Lakeland, FL 33805
Phone+1 863-345-4350

Summary

Actively engaged community based retina practice. Cover all aspects of Adult and some Pediatric retinal conditions. Offer state of the art medical and surgical services with upto date cutting edge diagnostic equipment. Typically in top 90 percentile in patient volume based on MGMA data analysis.

Utilize an advanced EHR called ModMed. State of documentation and interoperability with MIPS compliance.

Have worked in over 200 clinical studies to date - including major national and international trials as well as registry and in house studies.

Involved heavily in public presentations for international, national, regional and local CME conferences, pharmaceutical companies , political organizations, professional organizations, community groups, outreach groups and charities. Delivered over 100 presentations and contributed several times as an invited panelist.

Doximity Fellow, 2013
Selected for Doximity Fellowship, a prestigious group of physicians responsible for critiquing and curating the most relevant medical literature in Retinal Disease circulated to over 50% of US physicians. Also serves as a Doximity liaison providing product advice and strategic guidance to the company.

Education & Training

Medical College of Wisconsin Affiliated Hospitals, IncFellowship, Surgical Retina and Vitreous, 2004 - 2006
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2001 - 2003
University of ColoradoResidency, Surgery, 1998 - 2000
University of ColoradoInternship, Surgery, 1997 - 1998
Harvard Medical SchoolClass of 1997
Massachusetts General HospitalPost Sophomore Fellowship, Pathology Anatomic and Clinical, ABOP, 1994 - 1995
Harvard UniversityA.B., Chemistry, Magna Cum Laude, 1988 - 1992

Certifications & Licensure

CA State Medical License 2001 - Present
FL State Medical License 2006 - 2026
WI State Medical License 2004 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Physicians Recognition Award AMA, 2007, 2012, 2013
Meaningful Use Stage 1 Center for Medicare and Medicaid Services, 2012
Charter Member International Masters of Retina (IMOR), 2010
Member of the Council on Medical Economics Florida Medical Association, 2008, 2009, 2010
Physicians Recognition Award with Commendation AMA, 2008-2011, 2013
Marshal Harvard University Commencement, 1997
National Research Service Award Harvard Medical School, 1993
Kirkland House Masters Plate Award Harvard College, 1992
Varsity Letter Harvard Men’s Track and Field, 1990-1992, 1992
Varsity Letter Harvard Men’s Heavyweight Crew, 1990-1992, 1992
Justin Potter Scholarship Finalist Vanderbilt University School of Medicine, 1992
Dean’s List Harvard College 1988-1992, 1992
Magna cum laude in Chemistry Harvard College, 1992
John Harvard Scholarship Highest Academic Achievement Harvard College, 1990, 1991
Harvard College Scholarship High Academic Achievement Harvard College, 1989, 1990
State Record Shot Put Missouri 2A 1988, 1989
St. Louis Post-Dispatch Top Ten High School Scholar Athlete 1988
John Motley Morehead Scholarship University of North Carolina, Chapel Hill NC, 1988
National Merit Finalist John Burroughs School, 1988
Rensselaer Award Math and Science, John Burroughs School, 1988
Illinois State Scholar 1988
Class Numerals Freshman Football, Harvard College, 1988
National Latin Competition – Honorable Mention 1987
St. Louis University Physics Competition – Honorable Mention 1987
American Chemical Society Competition 3rd Place 1986
State Champion – Football Missouri 2A 1985
State Champion – Shot Put Missouri 2A
State Champion – Discus Missouri 2A
Join now to see all

Clinical Trials

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study Start of enrollment: 2004 Oct 01
Completed
Phase 3
A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration Start of enrollment: 2005 Jun 01
Terminated
Phase 3
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib Start of enrollment: 2005 Sep 01
Completed
Phase 3
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) Start of enrollment: 2006 Apr 01
Completed
Phase 2
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema Start of enrollment: 2007 Sep 01
Completed
Phase 3
Age-Related Eye Disease Study 2 (AREDS2) Start of enrollment: 2006 Sep 01
Completed
Phase 3
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD Start of enrollment: 2006 Jun 01
Unknown status
Phase 4
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Start of enrollment: 2005 Apr 01
Completed
Not Applicable
A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III) Start of enrollment: 2006 Dec 01
Completed
Phase 2
Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Start of enrollment: 2006 Dec 01
Completed
Phase 2
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Start of enrollment: 2007 Feb 01
Completed
Phase 3
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis Start of enrollment: 2007 Jan 01
Suspended
Phase 3
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) Start of enrollment: 2007 Jun 01
Completed
Phase 3
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) Start of enrollment: 2007 Jun 01
Completed
Phase 3
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) Start of enrollment: 2007 Jul 01
Completed
Phase 3
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) Start of enrollment: 2007 Jul 01
Completed
Phase 3
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD Start of enrollment: 2007 Aug 01
Terminated
Phase 3
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD Start of enrollment: 2007 Jul 01
Terminated
Phase 2
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Start of enrollment: 2007 Aug 01
Completed
Phase 3
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration Start of enrollment: 2007 Dec 01
Completed
Phase 1
Sensitivity of the Home Macular Perimeter (HMP) Start of enrollment: 2007 Nov 01
Completed
To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD Start of enrollment: 2008 Mar 05
Completed
Phase 2
Observational Study of DME Following Scatter Laser Photocoagulation Start of enrollment: 2005 Sep 01
Completed
Not Applicable
Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy Start of enrollment: 2008 Dec 01
Terminated
Phase 2
Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema Start of enrollment: 2008 Jun 01
Terminated
Phase 2
Evaluation of Vitrectomy for Diabetic Macular Edema Start of enrollment: 2005 Jul 01
Completed
ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration Start of enrollment: 2008 Jul 01
Completed
Phase 1
Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). Start of enrollment: 2009 Nov 01
Completed
Phase 2
An Extension to Study MD7108240 Start of enrollment: 2008 Jun 25
Completed
Phase 2
Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration Start of enrollment: 2008 Oct 01
Unknown status
Phase 1
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial. Start of enrollment: 2008 Dec 01
Completed
Phase 3
DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact Start of enrollment: 2008 Dec 01
Completed
Phase 2
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Start of enrollment: 2009 Jul 13
Terminated
Phase 4
A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR) Start of enrollment: 2009 Jul 01
Completed
Phase 3
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion Start of enrollment: 2010 Jan 01
Completed
Phase 2
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Start of enrollment: 2009 Jul 01
Completed
Phase 3
A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration Start of enrollment: 2009 Jul 01
Completed
Phase 1
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy Start of enrollment: 2010 Aug 05
Completed
Phase 1
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Start of enrollment: 2009 Oct 01
Completed
Phase 3
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration Start of enrollment: 2010 Jun 01
Completed
Phase 2
Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration Start of enrollment: 2011 Jun 01
Completed
Phase 2
A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy Start of enrollment: 2011 Feb 01
Completed
Phase 2
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration Start of enrollment: 2010 Nov 01
Completed
Phase 1
iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) Start of enrollment: 2011 Mar 01
Terminated
Phase 1
Study Assessing Double-masked Uveitis Treatment Start of enrollment: 2011 May 01
Completed
Phase 3
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema Start of enrollment: 2011 May 01
Completed
Phase 3
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD Start of enrollment: 2012 Aug 01
Completed
Phase 2
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) Start of enrollment: 2008 Jul 01
Completed
Not Applicable
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) Start of enrollment: 2012 Feb 01
Completed
Phase 2
Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) Start of enrollment: 2012 Apr 01
Completed
Phase 3
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) Start of enrollment: 2012 Jan 25
Completed
Phase 2
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration Start of enrollment: 2012 Aug 01
Terminated
Phase 2
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Start of enrollment: 2012 May 29
Terminated
Phase 2
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD). Start of enrollment: 2012 Dec 01
Terminated
Phase 2
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Start of enrollment: 2012 Aug 01
Terminated
Phase 3
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema Start of enrollment: 2012 Sep 01
Completed
Phase 1, Phase 2
Efficacy and Safety Study of ESBA1008 Versus EYLEA® Start of enrollment: 2013 Mar 01
Completed
Phase 2
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion Start of enrollment: 2013 May 01
Unknown status
Phase 4
ESBA1008 Microvolume Study Start of enrollment: 2013 Jun 01
Completed
Phase 2
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy Start of enrollment: 2013 Aug 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

Books/Book Chapters

Ophthalmology
Chapter: Retinal Toxicity of Systemically Administered Drugs
Page 761 - 765Hamilton R, Weinberg DEditors: Yanoff M, Duker J.Mossy Elsevier, LondonEdition 3,
The Retina Atlas (Expert Consult)
Chapter: Chapter 5 : Infection : Bacteria: Bartonella Henselae - photo essay
Page 342 - 342Hamilton REditors: Yanuzzi L.Saunders Elsevier, LondonEdition 1,
Optical Coherence Tomography in Retinal Diseases.
Chapter: Juxtafoveal Telangiectasias
Page 132 - 136R. Hamilton, J.E. Kim, R.F. Spaide

Abstracts/Posters

Review of Current Clinical Trials.
M. Tolentino et al, Journal Club – Center for Retina and Macular Disease, Center for Retina and Macular Disease, Winter Haven, FL
Choroidal Invasion: A Risk Factor for Clinical.
R. Hamilton, Behaviour in Retinoblastoma Doheny Days, Doheny Eye Institute, Los Angeles, CA
Clinically Significant Diabetic Macular Edema.
R. Hamilton, Allergan sponsored resident education, Milwaukee, WI
Retinal Angiomatous Proliferation.
R. Hamilton, Allergan sponsored resident education, Milwaukee, WI
Polypoidal Choroidal Vasculopathy.
R. Hamilton, Grand Rounds - Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
Impending Macular Hole.
R. Hamilton, Grand Rounds - Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
Case Presentations in Retina.
R. Hamilton et al, Journal Club – Center for Retina and Macular Disease, Center for Retina and Macular Disease Auditorium, Winter Haven, FL
The Basics of Optical Coherence Tomography.
R. Hamilton, Grand Rounds – Center for Retina and Macular Disease, Center for Retina and Macular Disease Auditorium, Winter Haven, FL
OCT: Case Presentations.
J. Moon et al, Journal Club – Center for Retina and Macular Disease, Center for Retina and Macular Disease Auditorium, Winter Haven, FL
OCT: Case Presentations.
J. Moon et al, Journal Club – Center for Retina and Macular Disease, Center for Retina and Macular Disease Auditorium, Winter Haven, FL
Case Presentation in Retina: POHS.
R. Hamilton et al, Grand Rounds – Center Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
Ophthalmic Manifestations of Sarcoidosis.
R. Hamilton, Doheny Days, Doheny Eye Institute, Los Angeles, CA
Diabetes Basic Science Review.
M. Tolentino et al, Grand Rounds – Center for Retina and Macular Disease, Lake Region Country Club Winter Haven, FL
The Genesis of PVD.
R. Hamilton et al, Journal Club – Center for Retina and Macular Disease, Lakeland Yacht and Country Club, Lakeland, FL
Interesting and Unusual Retina Cases: Where Do They Get These Cases.
D. Misch et al, Grand Rounds - Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
High Resolution OCT.
Adam Berger et al, Journal Club – Center for Retina and Macular Disease, Center for Retina and Macular Disease Auditorium, Winter Haven, FL
20G 23G and 25G Vitrectomy Solutions.
D. Misch et al, Grand Rounds – Center for Retina and Macular Disease, Lake Region Country Club Winter Haven, FL
Regeneron : New Horizons in AMD Management.
M. Tolentino et al, Journal Club – Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
New Horizons in AMD Management.
A. Berger and M Tolentino et al, Grand Rounds – Center for Retina and Macular Disease, Lake Region Country Club Winter Haven, FL
Geographic Atrophy – New Frontiers in Treatment.
R. Hamilton et al, Journal Club – Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
Interesting and Challenging Cases in Retina.
J. Moon et al, Grand Rounds – Center for Retina and Macular Disease, Lone Palm Country Club, Lakeland, FL
Uveitis Update.
R. Hamilton, Midwinter Symposium, Medical College of Wisconsin, Brookfield, WI
Regression of Choroidal Metastasis to Taxane Based Therapy.
K. Shiramizu, R. HAMILTON, J.I. Lim, ARVO
Intraocular Pressure Elevation after Subtenon’s Steroid Injection.
J.E. Kim, C.C. Patel, R. HAMILTON, ARVO
The Impact on Foveal Thickness in Response to Subtenon’s Steroid Injection.
C.C. Patel, J.E. Kim, R. HAMILTON, ARVO
Join now to see all

Lectures

Systemic Work-up for Retinal Vein Occlusion
Long Boat Key, Florida
Beyond the Era of Anti-VEGF: The Advent of Bioactive Lipids
Cap Cana, Dominican Republic
Wide Field Imaging: Clinical Decision Making in Retina
Cap Cana, Dominican Republic
New Developments in Chemical Vitreolysis
Cap Cana, Dominican Republic
Retinomics The Sequel
Disney World, Orlando, Florida
20 Guage Sutureless Vitrectomy
Punta Cana, Dominican Republic
Panelist - 3rd Annual Florida Retina Symposium
Davenport, Florida
Peripheral Retina and Pharmacologic Vitreolysis
Davenport, Florida
Retinomics
Sarasota, Florida
Fundus Autoflourescence - Panel Discussion Leader
Sarasota, Florida
Geographic Atrophy: New Imaging Techniques and Treatments
Davenport, Florida
Peripheral Retina and New Insights into Vitreous Separation
Davenport, Florida
Central Retinal Vein Occlusion
Lake Louise, Alberta, Canada
Bartonella Neuroretinitis
Lake Louise, Alberta, Canada
Join now to see all

Authored Content

My Eyes Were on CRAO at ASRS 2021October 2021

Press Mentions

Macular Diseases: Emerging Best Practices for Diagnosis, Management and Follow-up ProtocolsJanuary 22nd, 2020

Committees

Board Member, Florida Medical Association Rules and Credentials Committee 2012 - Present
Vice President, WeCare Board of Directors 2012 - Present
Board Member, Polk County Medical Association Board of Directors 2012 - Present
President, Polk County Medical Association Executive Committee 2012 - Present
Insurance Benefits Committee, CRMD Board of Directors 2011 - Present
Chairman of IT Committee, CRMD Board of Directors 2010 - Present
Member, Florida Medical Association Council on Economics 2009 - 2010